Preventive Healthcare Technologies and Services Market Report by Type (Early Detection and Screening, Vaccines, Chronic Diseases Management, Advanced Technologies to Reduce Errors), Application (Hospitals, Clinics, and Others), and Region 2025-2033

Preventive Healthcare Technologies and Services Market Report by Type (Early Detection and Screening, Vaccines, Chronic Diseases Management, Advanced Technologies to Reduce Errors), Application (Hospitals, Clinics, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A6209

Market Overview:

The global preventive healthcare technologies and services market size reached USD 330.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 805.3 Billion by 2033, exhibiting a growth rate (CAGR) of 9.5% during 2025-2033.

Report Attribute
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024 USD 330.6 Billion
Market Forecast in 2033 USD 805.3 Billion
Market Growth Rate (2025-2033) 9.5%


Preventive healthcare technologies and services refer to measures taken by healthcare providers to identify future illnesses and treatments. It includes early detection and screening, prophylaxis, chronic disease management, vaccines, and advanced technologies to reduce errors. Preventive healthcare technologies and services utilize various devices to measure daily health parameters, such as blood oxygen saturation, blood pressure, heart rate, and sleep patterns. This, in turn, assists healthcare professionals in screening, check-ups, and patient counseling to identify and prevent various health problems. As a result, they are extensively adopted in hospitals and clinics to eradicate, eliminate, and minimize the negative impact of various diseases.

Preventive Healthcare Technologies and Services Market Trends:

The rising geriatric population across the globe is creating a positive outlook for the market. Preventive healthcare technologies and services are widely adopted to prevent or identify problems at an early stage and decrease the risks of chronic illnesses, such as cardiovascular diseases (CVDs), diabetes, cancer, hypertension, respiratory ailments, and other contagious diseases. Furthermore, significant technological advancements in the healthcare system, coupled with the rising adoption of self-monitoring devices to increase awareness and reduce the cost burden, are acting as other growth-inducing factors. Additionally, the integration of artificial intelligence (AI) in healthcare technology to identify and predict diseases and provide personalized and accurate assumptions and treatment methods based on patients’ history is providing an impetus to the market growth. Moreover, the widespread adoption of cloud-based technologies to enhance operational efficiency, clinical quality, and delivery of preventive healthcare is further supporting market growth. Other factors, including the implementation of various government initiatives supporting vaccination programs to improve life expectancy, extensive research and development (R&D) activities, and increasing public awareness regarding preventive methods, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global preventive healthcare technologies and services market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on type and application.

Breakup by Type:

  • Early Detection and Screening
  • Vaccines
  • Chronic Diseases Management
  • Advanced Technologies to Reduce Errors
     

Breakup by Application:

  • Hospitals
  • Clinics
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, GlaxoSmithKline PLC, McKesson Corporation, Medtronic PLC, Merck & Co. Inc., Myriad Genetics, Omron Healthcare Inc., Pfizer Inc., Quest Diagnostics and Sanofi S.A.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Type, Application, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, GlaxoSmithKline PLC, McKesson Corporation, Medtronic PLC, Merck & Co. Inc., Myriad Genetics, Omron Healthcare Inc., Pfizer Inc., Quest Diagnostics and Sanofi S.A.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

We expect the global preventive healthcare technologies and services market to exhibit a CAGR of 9.5% during 2025-2033.

The rising integration of AI in healthcare technology to identify and predict diseases, along with to provide accurate assumptions and treatment methods based on the history of patients, is primarily driving the global preventive healthcare technologies and services market.

The sudden outbreak of the COVID-19 pandemic has led to the growing demand for preventive healthcare technologies and services for screening, check-ups, and patient counseling to detect and prevent various health problems related to the coronavirus infection.

Based on the type, the global preventive healthcare technologies and services market has been segregated into early detection and screening, vaccines, chronic diseases management, and advanced technologies to reduce errors. Among these, early detection and screening currently holds the largest market share.

Based on the application, the global preventive healthcare technologies and services market can be bifurcated into hospitals, clinics, and others. Currently, hospitals exhibit a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global preventive healthcare technologies and services market include Abbott Laboratories, GlaxoSmithKline PLC, McKesson Corporation, Medtronic PLC, Merck & Co. Inc., Myriad Genetics, Omron Healthcare Inc., Pfizer Inc., Quest Diagnostics, and Sanofi S.A.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Preventive Healthcare Technologies and Services Market Report by Type (Early Detection and Screening, Vaccines, Chronic Diseases Management, Advanced Technologies to Reduce Errors), Application (Hospitals, Clinics, and Others), and Region 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials